Health benefits of nongallated and gallated flavan-3-ols: A prospectus

Recent Advances in Gallate Research

Volumn , Issue , 2014, Pages 1-49

  Silva, Luís R ^a   Costa, Rui ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b INSTITUTO POLITÉCNICO DE COIMBRA   (Portugal)

Author keywords

Bioactive compounds; Nongallated and gallated flavan 3 ols; Phenolic compounds

Indexed keywords

BIOCHEMISTRY; CHEMICAL ANALYSIS; FOOD SUPPLY; ISOMERS; NEURODEGENERATIVE DISEASES; PLANTS (BOTANY); TANNINS;

BIOACTIVE COMPOUNDS; BIOLOGICAL POTENTIAL; CARDIO-VASCULAR DISEASE; DISTRIBUTED GROUPS; EPIDEMIOLOGICAL STUDIES; FLAVAN-3-OLS; PHENOLIC COMPOUNDS; SCIENTIFIC EVIDENCE;

FLAVONOIDS;

EID: 84949493544     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (179)

1. Paredes-López, O., Cervantes-Ceja, M. L., Vigna-Pérez, M. & Hérnandez-Pérez, T. (2010). Berries: Improving human health and healthy aging, and promoting quality - A review. Plant Foods for Human Nutrition, 65, 299-308.
2. Mudgal, V., Madaan, N., Mudgal, A. & Mishra, S. (2010). Dietary polyphenols and human health. Asian Journal of Biochemistry, 5, 154- 162.
3. Pandey, K. B. & Rizvi, S. I. (2009). Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Medicine and Cellular Longevity, 2 (5), 270-278.
4. Visioli, F., Lastra, C. A., Andres-Cueva, C., Aviram, M., Calhau, C., Cassano, A., D'Archivio, M., Faria, A., Favé, G., Fogliano, V., Llorach, R., Vitaglione, P., Zoratti, M. &, Edeas, M. (2011). Polyphenols and human health: a prospectus. Critical Reviews in Food Science and Nutrition, 51, 524-546.
5. Beckman, C. H. (2000). Phenolic-storing cells: keys to programmed cell death and periderm formation in wilt disease resistance and in general defence responses in plants? Physiological and Molecular Plant Pathology, 57, 101-110.
6. Silva, L. R., Valentão, P. & Andrade, P. (2012). Phenolic compounds in honey as a health promoters. In:. Bondurand, H. Bosch (Eds.). Honey: Production, Consumption and Health Benefits. Nova Science Publishers, Inc.; pp 81-111.
7. Graf, B. A., Milbury, P. E. & Blimberg, J. B. (2005). Flavonols, flavonones, flavanones and human health: epidemiological evidence. Journal of Medicinal Food, 8, 281-290.
8. Arts, I. C. W. & Hollman, P. C. H. (2005). Polyphenols and disease risk in epidemiologie studies. American Society for Clinical Nutrition, 81, 317-325.
9. Napolitano, A., Cascone, A., Graziani, G., Ferracane, R., Scalfi, L., Di Vaio, C., Ritieni, A. & Fogliano, V, (2004). Influence of variety and storage on the polyphenol composition of apple flesh. Journal of Agricultural and Food Chemistry, 52, 6526-6531.
10. Miglio, C., Chiavaro, E., Visconti A., Fogliano, V. & Pellegrini, N. (2008). Effects of different cooking methods on nutritional and physicochemical characteristics of selected vegetables. Journal of Agricultural and Food Chemistry, 56, 139-147.
11. Strack D. (1997). Plant Biochemistry. In: P. M. Dey & J. B. Harborne (Eds.), London: Academic Press, pp. 387-416.
12. Monagas., M, Bartolomé, B. & Gómez-Cordovés, C. (2005). Updated knowledge about the presence of phenolic compounds in wines. Critical Reviews in Food Science and Nutrition, 45, 85-118.
13. Crozier ,A., Jaganath, I. B. & Clifford, M. N. (2009). Dietary phenolics: chemistry, bioavailability and effects on health. Natural Product Reports, 26(8), 965-1096.
14. Fernandez, S. P., Wasowski, C., Loscalzo, L. M., Granger, R. E., Johnston, G. A.R, Paladini, A. C. & Marder, M. (2006) Central nervous system depressant action of flavonoid glycosides. European Journal of Pharmacology, 539, 168-176.
15. Marais, J. P., Deavours, B., Dixon, R. A. & Ferreira, D. (2006). The Science of Flavonoids. In: Grotewold, E. (Eds.), Ohio, USA: Springer Science and Business Media, Inc, Columbus, pp. 1-46.
16. Haslam, E. (1998). Practical polyphenols: from structure to molecular recognition and Physiological Action. Cambridge, UK: Cambridge University Press.
17. Harbone, J. B. (1986). Nature, distribution, and function of plant flavonoids. In: Cody V., Middleton, E., Harbone, J. B. (Eds.). Plant flavonoids in biology and medicine: biochemical, pharmacological, and structure-activity relationship. New York: Alan R. Liss.
18. Kühnau, J. (1976). The flavonoids, a class of semi-essential food components: their role in human nutrition. World Review of Nutrition and Dietetics, 24, 117.
19. Smith, G., Thomsen, S. J., Markham, K. R., Andary, C. & Cardon, D. (2000). The photostabilities of naturally occurring 5-hydroxyflavones, flavonols, their glycosides and their aluminium complexes. Journal of Photochemistry and Photobiology. A, Chemistry, 136, 87.
20. Erlund, I. (2004). Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavalability, and epidemiology. Nutrition Research, 24, 851-874.
21. Clifford, M. N. (1986). Interations of Food Components. In: G. G. Birch and M. G. Lindley (Eds.). London: Elsevier Applied Science, pp. 143- 164.
22. Henning, S. M., Choo, J. J., & Heber. D. (2008). Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. The Journal of Nutrition, Proceedings of the Fourth International Scientific Symposium on Tea and Human Health, 1529S-1534S.
23. Thangapazham, R. L., Passi, N. & Maheshwari, R. K. (2007). Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biology & Therapy, 6, 1938-1943.
24. Velayutham, P., Babu, A. & Liu, D. (2008). Green tea catechins and cardiovascular health: an update. Current Medicinal Chemistry, 15, 1840-1850.
25. da Silva Pinto, M. (2013). Tea: a new perspective on health benefits. Food Research International. In press. http://dx.doi.org/10.1016/j.foodres.2013.01.038.
26. Scholz, S. & Williamson, G. (2007). Interactions affecting the bioavailability of dietary polyphenols in vivo. International Journal for Vitamin and Nutrition Research. Supplement, 77, 224-235.
27. Aron, P. M. & Kennedy, J. A. (2008). Flavan-3-ols: nature, occurrence and biological activity. Molecular Nutrition & Food Research, 52, 79- 104.
28. Bruneton, J. (2009). Pharmacognosie, phytochimie, plantes médicinales, Lavoisier, Editions Tec & Doc.
29. Braicu, C., Pilecki, V., Balacescu, O., Irimie, A. & Neagoe, I. B. (2011). The relationships between biological activities and structure of flavan-3- ols. International Journal of Molecular Sciences, 12, 9342-9353.
30. Braicu, C., Rugina, D., Chedea, V. S., Balacescu, L., Brie, I., Soritau, O., Socaciu, C. & Irimie, A. (2010). Protective action of different natural flavan-3-ols against aflatoxin B1-related cytotoxicity. Journal of Food Biochemistry, 34, 595-610.
31. Del Rio, D., Stewart, A. J., Mullen, W., Burns, J., Lean, M. E., Brighenti, F. & Crozier, A. (2004). HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. Journal of Agricultural and Food Chemistry, 52, 2807-2815.
32. Del Rio, D., Calani, L., Cordero, C., Salvatore, S., Pellegrini, N., Brighenti, F. (2010). Bioavailability and catabolism of green tea flavan- 3-ols in humans. Nutrition, 26(11-12):1110-1116.
33. Duthie, G. G. & Crozier, A. (2003). Beverages. In: Goldberg, G. (Eds.). Plants: Diet and Health. London: British Nutrition Foundation, Chapman Hall, pp 147-182.
34. Ashihara, H., Deng, W-W., Mullen, W. & Crozier, A. (2010). Distribution and biosynthesis of flavan-3-ols in Camellia sinensis seedlings and expression of genes encoding biosynthetic enzymes. Pytochemistry, 71, 559-566.
35. De Pascual-Teresa, S., Santos-Buelga, C. & Rivas-Gonzalo, J C (2000). Quantative analysis of flavan-3-ols in Spanish foodstuffs and beverages. Journal of Agriculture and Food Chemistry, 48, 5331-5337.
36. Finger, A., Kuhr, S., Engelhardt, U. H. (1992). Chromatography of tea constituents. Journal of Chromatography, 624, 293-315.
37. Balentine, D. A., Wiseman, S. A. & Bouwens, L. C. M. (1997). The chemistry of tea flavonoids. Critical Reviews in Food Science and Nutrition, 37, 693-704.
38. Yiannakopoulou, E. C. (2013). Effect of green tea catechins on breast carcinogenesis: a systematic review of in-vitro and in-vivo experimental studies. European Journal of Cancer Prevention. In press.
39. Cabana, R., Silva, L. R., Valentão, P., Viturro, C. I. & Andrade, P. B (2013). Effect of different extraction methodologies on the recovery of bioactive metabolites from Satureja parvifolia (Phil.) Epling (lamiaceae). Industrial Crops and Products, 48, 49-56.
40. Carando, S., Teissedre, P-L., Pascual-Martinez, L. & Cabanis, J-C (1999).Levels of flavan-3-ols in French wines. Journal of Agriculture and Food Chemistry, 47, 4161- 4166.
41. Silva, L. R., Andrade, P. B., Valentão, P., Seabra, R. M., Trujillo, M. E. & Velazquez, E. (2005). Analysis of non-coloured phenolics in red wine: Effect of Dekkera bruxellensis yeast. Food Chemistry, 89, 185- 189.
42. Gu, L., Kelm, M. A., Hammerstone, J. F., Beecher, G., Holden, J., Haytowitz, D. & Prior, R. L. (2003). Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. Journal of Agriculture and Food Chemistry, 51, 7513-7521.
43. Marks, S. C., Mullen, W. & Crozier, A. (2007). Flavonoid and hydroxycinnamate profiles of english apple ciders. Journal of Agriculture and Food Chemistry, 55, 8723-8730.
44. Wang, Y. & Ho, C. T. (2009). Metabolism of Flavonoids. In Yoshikawa T. (Eds.), Food Factors for Health Promotion. Forum Nutrition Basel, Karger, 61, pp 64-74.
45. Li, S. & Ho, C.T. (2013). Metabolism, bioavailability, and safety features of green tea polyphenols. In Lekh R. Juneja, Mahendra P. Kapoor, Tsutomu Okubo, Theertham P. Rao Eds.), Green tea polyphenols: nutraceuticals of modern life. Boca Raton: CRC Press.
46. van de Waterbeemd, H., Lennernas, H. & Artursson, P. (2003). Drug bioavailability. Estimation of solubility, permeability, absorption and bioavailability. Weinheim: Wiley-VCH.
47. Auger, C., Mullen, W., Hara, Y. & Crozier, A. (2008). Bioavailability of polyphenols. Flavan-3-ols in humans with an ileostomy. The Journal of Nutrition, Proceedings of the Fourth International Scientific Symposium on Tea and Human Health.
48. Calani, L., Del Rio, D., Callegari, M. L., Morelli, L. & Brighenti, F. (2012). Updated bioavailability and 48 h excretion profile of flavan-3- ols from green tea in humans. International Journal of Food Sciences and Nutrition, 63(5), 513-521.
49. Yan, Z. & Caldwell, G. W. (2001). Metabolism profiling, and cytochrome P450 inhibition and induction in drug discovery. Current Topics in Medicinal Chemistry, 1, 403-425.
50. Lambert, J. D., Sang, S. & Yang, C. S. (2007). Biotransformation of green tea polyphenols and the biological activities of those metabolites. Molecular Pharmaceutics, 4 (6), 819-825.
51. Thilakarathna, S. H. & Rupasinghe, H. P. V. (2013). Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients, 5, 3367-3387.
52. Feng, Y. W. (2006). Metabolism of green tea catechins: An overview. Current Drug Metabolism, 7, 755-809.
53. Prior, R. L., Wu, X. & Gu, L. (2006). Perspective flavonoid metabolism and challenges to understanding mechanics of health effects. Journal of the Science of Food and Agriculture, 86, 2487-2491.
54. Tsang, C., Auger, C., Mullen, W., Bornet, A., Rouanet, J. M., Crozier, A. & Teissedre, P. L. (2006). The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. The British Journal of Nutrition, 95, 847.
55. Fernandes, I., Nave, F., Gonçalves, R., de Freitas, V. & Mateus, N. (2012). On the bioavailability of flavanols and anthocyanins: Flavanol- anthocyanin dimers. Food Chemistry, 135, 812-818.
56. Manach, C., Williamson, G., Morand, C., Scalbert, A. & Rémésy, C. (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition, 8, 230S- 242S.
57. Cos, P., De Bruyne, T., Hermans, S., Apers, S., Berghe, D. V. & Vlietinck, A. J. (2003). Proanthocyanidins in health care: current and new trends. Current Medicinal Chemistry, 10, 1345-1359.
58. Beecher, G. (2004). Proanthocyanidins: biological activities associated with human health. Pharmaceutical Biology, 42, 2-20.
59. Socha, R., Baczkowicz, M., Fortuna, T., Kura, A., Labanowska, M. & Kurdziel, M. (2013). Determination of free radicals and flavan-3-ols content in fermented and unfermented teas and properties of their infusions. European Food Research and Technology, 237, 167-177.
60. Rice-Evans, C. A., Miller, N. J. & Paganga, G. (1996). Structureantioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology & Medicine, 20, 9333-956.
61. deFreitas, V. A. P., Glories, Y. &, Laguerre, M. (1998). Incidence of molecular structure in oxidation of grape seed procyanidins. Journal of Agriculture and Food Chemistry, 46, 376-382.
62. Zhao, M. M., Yang, B., Wang, J. S., Li, B. Z. & Jiang, Y. M. (2006). Identification of the major flavonoids from pericarp tissues of lychee fruit in relation to their antioxidant activity. Food Chemistry, 98, 536- 544.
63. Plumb G. W., De Pascual-Teresa, S., Santos-Buelga, C., Cheynier, V. & Williamson, G. (1998). Antioxidant properties of catechins and proanthocyanidins: effect of polymerization, galloylation and glycosylation. Free Radical Research, 29, 351-358.
64. Kavanagh, K. T., Hafer, L. J., Kim, D. W., Mann, K. K., Sherr, D. H., Rogers, A. E. & Sonenshein, G. E. (2001). Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. Journal of Cellular Biochemistry, 82, 387-398.
65. Guo, Q., Zhao, B., Shen, S., Hou, J., Hu, J. & Xin, W. (1999). ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochimica et Biophysica Acta, 1427, 13-23.
66. Chobot, V., Huber, C., Trettenhahn, G. & Hadacek, F. (2009). (±)- Catechin: Chemical weapon, antioxidant, or stress regulator. Journal of Chemical Ecology, 35, 980-996.
67. Nanjo, F., Mori, M., Goto, K. & Hara, Z. (1999) Radical scavenging activity of tea catechins and their related compounds. Bioscience, Biotechnology, and Biochemistry, 6, 1621-1623.
68. Heim, K. E., Tagliaferro, A. R. & Bobilya, D. J. (2002). Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. The Journal of Nutritional Biochemistry, 13, 572-584.
69. Yang, C. S., Kim, S., Yang, G. Y. & Lee, M. J. (1999). Inhibition of carcinogenesis by tea: Bioavailability of tea polyphenols and mechanisms of actions. Proceedings of the Society for Experimental Biology and Medicine, 220, 213-217.
70. Dwibedy, P., Dey, G. R., Naik, D. B., Kishore, K. & Moorthy, P. N. (1999). Pulse radiolysis studies on redox reactions of gallic acid: One electron oxidation of gallic acid by gallic acid-OH adduct. Physical Chemistry Chemical Physics, 1, 1915-1918.
71. Weisburg, J. H., Weissman, D. B., Sedaghat, T. & Babich, H. (2004). In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity. Basic & Clinical Pharmacology & Toxicology, 95, 191-200.
72. Chung, K-T., Wong, T. Y., Wei, C-I., Huang, Y-W. & Lind, Y. (1998). Tannins and human health: a review. Critical Reviews in Food Science and Nutrition, 38(6), 421-464.
73. Ma, C. M., Nakamura, N., Miyashiro, H., Hattori, M. & Shimotohno, K. (1999). Inhibitory effects of constituents from Cynomorium songaricum and related triterpenes derivatives on HIV-1 protease. Chemical & Pharmaceutical Bulletin, 47, 141-145.
74. Hashimoto, F., Kashiwada, Y., Nonaka, G., Nishioka, I., Nohara, T., Cosentino, L. M. & Lee, K. H. (1996). Evaluation of tea polyphenols as anti-HIV agents. Bioorganic & Medicinal Chemistry Letters, 6, 695-700.
75. Nakane, H. & Ono, K. (1990). Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry, 29, 2841-2845.
76. Jin, S., Eerdunbayer, Doi, A., Kuroda, T., Zhang, G., Hatano, T. & Chen, G. (2012). Polyphenolic constituents of Cynomorium songaricum Rupr. And antibacterial effect of polymeric proanthocyanidin on methicillin-resistant Staphylococcus aureus. Journal Agriculture of Food Chemistry, 60, 7297-7305.
77. Chung, K-T., Stevens, S. E. Jr., Lin, W-F. & Wei, C. I. (1993). Growth inhibition of selected food-borne bacteria by tannic acid, propyl gallate and related compounds. Letters in Applied Microbiology, 17, 29-32.
78. Akiyama, H., Fujii, K., Yamasaki, O., Oono, T. & Iwatsuki, K. (2001). Antibacterial action of several tannins against Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 48, 487-491.
79. Shiota, S., Shimizu, M., Mizushima, T., Ito, H., Hatano, T., Yoshida, T. & Tsuchiya, T. (1999). Marked reduction in the minimum inhibitory concentration (MIC) of ß-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis). Biological and Pharmaceutical Bullentin, 22, 1388-1390.
80. Kusuda, M., Inada, K., Ogawa, T. O., Yoshida, T., Shiota, S., Tsuchiya, T. & Hatano, T. (2006). Phenolic constituent structures of Zanthoxylum pipericum fruit and the antibacterial effects of its polymeric procyanidin on methicillin-resistant Staphylococcus aureus. Bioscience, Biotechnology, and Biochemistry, 70, 1423-1431.
81. Stapleton, P. D., Shah, S., Anderson, J. C., Hara, Y., Hamilton-Miller, J. M. T. & Taylor, P. W. (2004). Modulations of ß-lactam resistance in Staphycococcus aureus by catechins and gallates. International Journal of Antimicrobial Agents, 23, 462-467.
82. Takahashi, O., Cai, Z., Toda, H., Hara, Y. & Shimamura, T. (1995). Appearance of antibacterial activity of oxacillin against methicillin resistant Staphylococcus aureus (MRSA) in the presence of catechin. Journal of the Japan Association for Infectious Disease, 69, 1126-1134.
83. Li, X. C., ElSohly, H. N., Nimrod, A. C. & Clark, A. M. (1999). Antifungal activity of (-)-epigallocatechin gallate from Coccoloba dugandiana. Planta Medica, 65(8), 780.
84. Saito, H., Tamura, M., Imai, K., Ishigami, T. & Ochiai, K. (2013). Catechin inhibits Candida albicans dimorphism by disrupting Cek1 phosphorylation and cAMP synthesis. Microbial Pathogenesis, 56, 16- 20.
85. Molan, A. L., Sivakumaran, S., Spencer, P. A. & Meagher, L. P. (2004). Green tea flavan-3-ols and oligomeric proanthocyanidins inhibit the motility of infective larvae of Teladorsagia circumcincta and Trichostrongylus colubriformis in vitro. Research Veterinary Science, 77, 239-243.
86. Paveto, C., Guida, M. C., Esteva, M. I., Martino, V., Coussio, J., Flawiá, M. M. & Torres, H. N. (2004). Anti-Trypanosoma cruzi activity of green tea (Camellia sinensis) catechins. Antimicrobial Agents and Chemotherapy, 48(1), 69-74.
87. Min, B. R. & Hart, S. P. (2003). Tannins for suppression of internal parasites. Journal of Animal Science, 81, E102-E109.
88. Yang, C. S., Sang, S., Lambert, J. D. & Lee, M. J. (2008). Bioavailability issues in studying the health effects of plant polyphenolic compounds. Molecular Nutrition & Food Research, 52 (Suppl.1), S139- S151.
89. Lee, M. J., Maliakal, P., Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., Lambert, G., Mohr, S. & Yang, C. S. (2002). Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiology, Biomarkers & Prevention, 11, 1025-1032.
90. Alavijeh, M. S., Chishty, M., Qaiser, M. Z., Palmer, A. M. (2005). Drug metabolismo and pharmacokinetics, the blood barrier, and central nervous system drug discovery. NeuroRx, 2, 554-571.
91. Ferrero-Miliani, I., Nielsen, O. H., Andersen, P. S. & Girardini, S. E. (2007). Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clinical and Experimental Immunology, 147, 227-235.
92. Shahidi, F. & Zhong, Y. (2009). Antioxidants, polyphenols and adipose inflammation. In A. B. Awad & P. G. Bradford (Eds.). Adipose tissue and inflammation Boca Raton, FL: CRC Press, Taylor & Francis Inc, pp. 233-234.
93. Kamada, H. & Hirata, H. (1999). Redox regulation of cellular signaling. Cellular Signalling., 11, 1-14.
94. Pan, M. H., Yang, J. R., Tsai, M. L. & Ho, C. T. (2009). Antiinflammatory effect of Momordica grovesnori Swingle extract through suppressed LPS-induced upregulation of iNOS and COX-2 in murine macrophages. Journal of Functional Foods, 1, 145-152.
95. Mann, J. R., Backlund, M. G. & DuBois, R. N. (2005). Mechanisms of disease: inflammatory mediators and cancer prevention. Nature Clinical Practice Oncology, 2, 202-210.
96. Chaudhuri, A. K., Karmakar, S., Roy, D., Pal, S., Pal, M. & Sen, T. (2005). Anti-inflammatory activity of Indian black tea (Sikkim variety). Pharmacological Research, 51, 169-175.
97. Tedeschi, E., Menegazzi, M., Yao, Y., Suzuki, H., Forstermann, U. & Kleinert, H. (2004). Green tea inhibits inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1a activation. Molecular Pharmacology, 65, 111-210
98. Bodet, C., Chandad, F. & Grenier, D. (2006). Anti-inflammatory activity of high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. Journal of Dental Research, 85, 235-239.
99. Singh, U., Tabibian, J., Venugopal, S. K., Devaraj, S. & Jialal, I. (2005). Development of na in vitro screening assay to test the anti-inflammatory properties of dietary supplements and pharmacologic agents. Clinical Chemistry, 51, 2252-2256.
100. Ichikawa, D., Matsui, A., Imai, M., Sonoda, Y. & Kasahara, T. (2004). Effect of various catechins on IL-12p40 production by murine peritoneal macrophages and a macrophage cell line J774.1. Biological & Pharmaceutical Bulletin, 27, 1353-1358.
101. Yang, G-Y., Liao, J., Kim, K., Yurkow, E. J. & Yang, C. S. (1998). Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis, 19, 611-616.
102. Ahmed, S., Rahman, A., Hasnain, A., Lalonde, M., Goldberg, V. M. & Haqqi, T. M. (2002). Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrpcytes. Free Radical Biology & Medicine, 33, 1097-1105.
103. Cui, Y., Kim, D. S., Park, S. H., Yoon, J. A., Kim, S. K., Kwon, S. B. & Park, K. C. (2004). Involvement of ERK and p38 MAP kinase in AAPH-induced COX-2 expression in Hacat cells. Chemistry and Physics of Lipids, 129, 43-52.
104. Hussain, T., Gupta, S., Adhami, V. M. & Mukhtar, H. (2005). Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. International Journal of Cancer, 113, 660-669.
105. Porath, D., Riegger, C., Drewe, J. & Schwager, J. (2005). Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. The Journal of Pharmacology and Experimental Therapeutics, 315, 1172-1180.
106. Babu, P. V. A. & Liu, D. (2013). Recent advances in understanding the anti-diabetic actions of dietary flavonoids. Journal of Nutritional Biochemistry, 24, 1777-1789.
107. Li, D.-Q., Quia, Z.-M. & Li, S.-P. (2010). Inhibition of three selected beverages extracts on a-glucosidase and rapid identification of their active compounds using HPLC-DAD-MS/MS and biochemical detection. Journal of Agriculture and Food Chemistry, 58(11), 6608- 6613.
108. Ma, C.-M., Sato, N., Li, X-Y., Nakamura, N. & Hattori, M. (2010). Flavan-3-ol contentes, anti-oxidative and a-glucosidase inhibitory activities of Cynomorium songaricum. Food Chemistry, 118, 116-119.
109. Iso, H., Date, C., Wakai, K., Fukui, M. & Tamakoshi, A. (2006). The relationship between green tea and total caffeine intake and risk for selfreported type-2 diabetes among Japanese adults. Annals of Internal Medicine, 144, 554.562.
110. Odegaard, A. O., Pereira, M. A., Koh, W-P., Arakawa, K., Lee, H-P. & Yu, M. C. (2008). Cofee, tea and incident type 2 diabetes: The Singapore Chinese health study. American Journal of Clinical Nutrition, 88, 979-985.
111. Huxley, R., Lee, C. M. Y., Barzi, F., Timmermeister, L., Czernichow, S., Perkovic, V., Grobbee, D. E., Batty, D. & Woodward, M. (2009). Coffee, decaffeinated coffe, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-analysis. Archives of Internal Medicine, 169, 2053-2063.
112. Hosoda, K., Wang, M. F., Liao, M. L., Chuang, C. K., Ilha, M., Clevidence, B. & Yamamoto, S. (2003). Antihyperglycemic effect of oolong tea in type-2 diabetes. Diabetes Care, 26, 1714-1718.
113. Rizvi, S. I., Zaid, M. A., Anis, R. & Mishra, N. (2005). Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clinical and Experimental Pharmacology & Physiology, 32, 70-75.
114. Tsuneki, H., Ishizuka, M., Terasawa, M., Wu, J. B., Sasaoka, T. & Kymura, I. (2004). Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic /db/db) mice and on glucose metabolism in healthy humans.BMC Pharmacology, 4, 18.
115. Kao, Y. H., Hiipakka, R. A., Liao, S. (2000). Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Encodrinology, 141, 980-987.
116. Besser, G.M. & Thorner, M. O. (2002). Comprehensive Clinical Endocrinology (3rd edn.), MOSBY, an affiliate of Elsevier Science, London.
117. Matsumoto, N., Ishigaki, F., Ishigaki, A., Iwashina, H. & Hara, Y. (1993). Reduction of blood glucose levels by tea catechin. Bioscience, Biotechnology, and Biochemistry, 57, 525-527.
118. Ortsäter, H., Grankvist, N., Wolfram, S., Kuehn, N. & Sjöholm, A, (2012). Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutrition & Metabolism, 9, 11.
119. Sabu, M. C., Smitha, K. & Kuttan, R. L. (2002). Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. Journal of ethnopharmacology, 83, 109-116.
120. Nussbaum, R. L. & Ellis, C. E. (2003). Alzheimer's disease and Parkinson's disease. The New England Journal of Medicine, 348(14), 1356-1364.
121. Jellinger, K. A. (2001). Ell death mechanisms in neurodegeneration. Journal of Cellular and Molecular Medicine, 5, 1-17.
122. Lindsay, J., Laurin, D., Verreault, R., Hebert, R., Helliwell, B., Hill, G. B. & McDowell, I. (2002). Risk factors for Alzheimer's disease: A prospective analysis from the Canadian study of health and aging. American Journal of Epidemiology, 156, 445-453.
123. Commenges, D., Scotet, V., Renaud, S., Jacqmin-Gadda, H., Barberger-Gateau, P. & Dartigues, J. F. (2000). Intakes of flavonoids and risk of dementia. European Journal of Epidemiology, 16, 357-363.
124. Letenneur, L., Proust-Lima, C., Le, G. A., Dartigues, J. F. & Barberger-Gateau, P. (2007). Flavonoid intake and cognitive decline over a 10 year period. American Journal of Epidemiology, 165, 1364-1472.
125. Dai, Q., Borenstein, A. R., Wu, Y., Jackson, J. C. & Larson, E. B. (2006). Fruit and vegetable juices and Alzheimer's disease: the kame project. The American Journal of Medicine, 119, 751-759
126. Ng, T-P., Feng, I., Niti, M., Kua, E-H. & Yap, K-B. (2008). Tea consumption and cognitive impairment and decline in older Chinese adults. American Journal of Clinical Nutrition, 88, 224-231.
127. Niu, K., Hozawa, A., Kuryama, S., Ebihara, S., Guo, H., Nakaya, N. et al., (2009). Green tea consumption is associated with depressive symptoms in the elderly. The American Journal of Clinical Nutrition, 90, 1615-1622
128. Tan, E. K., Fook-Chong, S. M., Lum, S. Y., Chai, A., Chung, H., Shen, H., Zhao, Y., Teoh, M. L., Yih, Y., Pavanni, R., Chandram, V. R. & Wong, M. C. (2003). Dose-dependent protective effect of coffee, tea and smoking in Parkinson's disease: a study in ethnic Chinese. Journal of the Neurological Sciences, 216, 163-167.
129. Chekoway, H., Powers, K., Smith-Weller, T., Franklin, G. M., Longstreth, W. T. Jr. & Swanson, P. D. (2002). Parkinson's disease mumption, and caffeine intake. American Journal of Epidemiology, 155, 732-738.
130. Bastianetto, S., Yao, Z-X., Papadopoulos, V. & Quirion, R. (2006). Neuroprotective effects of green and black teas and their catechin gallate esters against ß-amyloid-induced toxicity. European Journal of Neuroscience, 23, 55-64.
131. Youdim, K. A., Qaiser, M. Z., Begley, D. J., Rice-Evans, C. A. & Abbott, N. J. (2004). Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radical Biology & Medicine, 36, 592-604.
132. Zini, A., Del Rio, D., Stewart, A. J., Mandrioli, J., Merelli, E., Sola, P., Serafini, M., Serafini, M., Brighenti, F., Edwards, C. A. & Crozier, A. (2006). Do flavan-3-ols From Green tea reach the human brain? Nutritional Neuroscience, 9, 57-61.
133. Kerns, E. H. & Di, L. (2008). Blood-brain barrier. In E. H. Kerns & I. Di (Eds.), Drug-like properties: concepts, structure design and methods, from ADME to toxicity optimization. London: Academic Press-Elsevier, pp. 122-136.
134. Lee, S. Y., Lee, J. W., Lee, H., Yoo, H. S., Yun, Y. P., Oh, K. W., Ha, T. Y. & Hong, J. T. (2005). Inhibitory effect of green tea extract on ß- amyloid-induced PC12 cell death by inhibition of the activation of NF.kB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Research. Molecular Brain Research, 140, 45/54.
135. Choi, H. T., Pae, H. O., Choi, B. M., Billiar, T. R. & Kim, Y. M. (2001). Nitric oxide as a bioregulator of apoptosis. Biochemical and Biophysical Research Communications, 282, 1075-1079.
136. Ban, J. Y., Jeon, S. Y., Bae, K., Song, K. S. & Seong, Y. H. (2006). Catechin and epicatechin from Smilacis chinae rhizome protect cultured rat cortical neurons against amyloid ß protein (35)-induced neurotoxicity through inhibition of cytosolic calcium elevation. Life Science, 79, 2251- 2259.
137. Tanasescu, M., Leitzmann, M. F., Rimm, E. B., Willet, W. C., Strampfer, M. J. & Hu F. B. (2002). Exercise type and intensity in relation to coronary heart disease in men. JAMA, 288, 1994-2000.
138. Hooper, L., Kay, C., Abdelhamid, A., Kroon, P., Chn, J. S., Rimm, E. B. & Aedín-Cassidy (2012). Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analises of randomized trials. The American Journal of Clinical Nutrition, 95, 740- 751.
139. Bagchi, D. B., Sen, C. K., Ray, S. D., Das, D. K., Bagchi, M., Preuss, H. G. & Vinson, J. A. (2003). Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutation Research- Fundamental and Molecular Mechanisms of Mutagenesis, 523, 87-97.
140. Rasmussen, S. E., Frederiksen, H., Krogholm, K. S. & Poulsen, L. (2005). Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Molecular Nutrition & Food Research, 49, 159-174.
141. Ottaviani, J. I., Actis-Goretta, L., Villordo, J. J. & Fraga, C. G. (2006). Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition. Biochimie, 88, 359-365.
142. Vita, J. A. (2003). Tea consumption and cardiovascular disease: effects on endothelial function. The Journal of Nutrition, 133, 3293S-3297S.
143. Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., Nakaya, N., Nishino, Y., Tsubono, Y. & Tsuji, I. (2006). Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. Jama, 296, 1255-1265.
144. Imai, K. & Nakachi, K. (1995). Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ, 310, 693- 696.
145. Shenouda, S. M. & Vita, J. A. (2007). Effects of flavonoid-containing beverages and EGCG on endotelial function. Journal of the American College of Nutrition, 26, 366S-372S.
146. Stoclet, J. C., Kleschyov, A., Andriambeloson, E., Diebolt, M. & Andriantsitohaina, R. (1999). Endothelial NO release caused by red wine polyphenols, Journal of Physiology and Pharmacology, 50, 535-540.
147. Fitzpatrick, D. F., Fleming, R. C., Bing, B., Maggi, D. A., O'Malley, R. M. (2000). Isolation and characterization od endothelium-dependent vasorelaxing compounds from grape seeds. Journal of Agriculture and Food Chemistry, 48, 6384-6390.
148. Tomero, J. F. (1999). Current knowledge of the health benefits and disadvantages of wine consumption. Trends in Food Science & Technology, 10, 129-138.
149. Steinberg, F. M., Holt, R. R., Schmitz, H. H. & Keen, C. L. (2002). Cocoa procyanidin chain lenght does not determine ability to protect LDL from oxidation when monomer units are controlled. The Journal of Nutritional Biochemistry, 13, 645-652.
150. Serafini, M., Laranjinha, J. A., Almeida, L. M. & Maiani, G., (2000). Inhibition of human LDL lipid peroxidation by phenol-rich beverages and their impact on plasma total antioxidant capacity in humans. The Journal of Nutritional Biochemistry, 11, 585-590.
151. Sung, H., Min, W. K., Lee, W., Chun, S., Park, H., Lee, Y. W., Jang, S. & Lee, D. H. (2005). The effects of green tea ingestion over 4 weeks on atherosclerotic markers. Annals of Clinical Biochemistry, 42, 292-297.
152. Actis-Goretta, L., Ottaviani, J. I. & Fraga, C. G. (2006). Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. Journal of Agriculture and Food Chemistry, 54, 229-234.
153. Wood, C. G. (2007). Multimodal approaches in the management of locally advanced and metastic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clinical Cancer Research, 13, 697s-702s.
154. Randhawa, M. A. & Alghamdi, M. S. (2011). Anticancer activity of Nigella sativa (black seed)-A review. The American Journal of Chinese Medicine, 39, 1075-1091.
155. Xu, Z., Chen, X., Zhong, Z., Chen, L. & Wang, Y. (2011). Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. American Journal of Chinese Medicine, 39, 15-27.
156. Huang, W. Y., Cai, Y. Z. & Zhang, Y. (2010). Natural phenolic compounds from medicinal herbs and dietary plants: potential use of cancer prevention. Nutrition and Cancer, 62, 1-20.
157. Lambert, J. D., Hong, J. & Yang, G. Y. (2005). Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. The American Journal of Clinical Nutrition, 81, 284-291.
158. Lawless, M. W., O'Byrne, K. J. & Gray, S. G. (2010). Targeting oxidative stress in cancer. Expert Opinion on Therapeutic Targets, 14, 1225-1245.
159. Zaveri, N. T. (2006). Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Science, 78, 2073-2080.
160. Mak, J. C. (2012). Potential role of green tea catechins in various disease therapies: progress and promise. Clinical and Experimental Pharmacology & Physiology, 39, 265-273.
161. Yuan, J-M. (2013). Cancer prevention by green tea: evidence from epidemiologic studies. The American Journal of Clinical Nutrition, Doi:10.3945/ajcn.113.058271.
162. Yang, C. S., Wang, X., Lu, G. & Picinish, S. C. (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nature Reviews. Cancer, 9, 429-439.
163. Li, B., Zhao, J., Wang, C. Z., Searle, J., He, T. C., Yuan, C. S. & Du, W. (2011). Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cell through activation of p53. Cancer Letters, 301, 185-192.
164. Rodriguez, M., Du, G. J., Wang, C. Z. & Yuan, C. S. (2010). Letter to the editor: Panaxadiol's anticancer activity is enhanced by epicatechin. The American Journal of Chinese Medicine, 38, 1233-1235.
165. Du, G-J., Zhang, Z., Wen, X-D., Yu, C., Yu, C., Calway, T., Yuan, C-S. & Wang, C-Z. (2012). Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients, 4, 1679-1691.
166. Singh, B. N., Shankar, S. & Srivastava, R. K. (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemistry & Pharmacology, 82, 1807-1821.
167. Du, G. J., Wang, C. Z., Qi, L. W., Zhang, Z. Y., Calway, T., He, T. C., Du, W. & Yuan, C. S. (2012). The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells. Phytotherapy Research. Doi:10.1002/ptr.4707.
168. Wang, C. Z., Luo, X., Zhang, B., Song, W. X., Ni, M., Mehendale, S., Xie, J. T., Aung, H. H., He, T. C. & Yuan, C. S. (2007). Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemotherapy and Pharmacology, 60, 69-79.
169. Singh, T. & Katiyar, S. K. (2013). Green tea polyphenols, (-)- epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting ß-catenin signaling. Toxicology and Applied Pharmacology, doi: org/10.1016/j.taap.2013.09.021.
170. Lin, Y. L. & Lin, J. K. (1997). (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappa B. Molecular Pharmaceutics, 52, 465-472.
171. Chung, L. Y., Cheung, T. C., Kong, S. K., Fung, S. K., Fung, K. P., Choy, Y. M., Chan, Z. Y., Kwok, T. T. (2001). Induction of apoptosis by green tea catechins in human prostate cancer DU 145 cells. Life Sciences, 68, 1207-1214.
172. Jeong, W., S., Kim, I. W., Hu, R. & Kong, A. N. T. (2004). Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line. Pharmaceutical Biology, 21, 649-660.
173. Chen, C., Shen, G., Hebbar, V., Hu, R., Owuor, E, D. & Kong, A. N. (2003). Epigallocatechin-3-gallate induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis, 24, 1369-1378.
174. Mazzanti, G., Menniti-Ippolito, F., Moro, P. A., Cassetti, F., Raschetti, R., Santuccio, C. & Mastrangelo, S. (2009). Hepatotoxicity from green tea: a review of the literature and two unpublished cases. European Journal of Clinical Pharmacology, 65, 331-341.
175. Lambert, J. D., Kenett, M. J., Sang, S., Reuhl, K. R., Ju, J. & Yang, C. S. (2010). Hepatotoxicity of high oral dose (-)-epigallocatechins-3-gallate in mice. Food Chemical Toxicology, 48, 409-416.
176. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., Joshi, S. S. & Pruess, H. G. (2000). Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology, 148, 187-197.
177. Ramljak, D., Romanczyk, L. J., Metheny-Barlow, L. J., Thompson, N., Knezevic, V., Galperin, M., Ramesh, A. & Dickson, R. B. (2005). Pentameric procyanidin from Theobroma cacao selectivity inhibits growth of human breast cancer cells. Molecular Cancer Therapeutics, 4, 537-546.
178. Schmidt, B. M., Erdman, J. W. & Lila, M. A. (2006). Differential effects of bluberry proanthocyanidins on androgen sensitive and insensitive human prostate cancer cell lines. Cancer Letters, 231, 240-246.
179. Schmidt, B. M., Howell, A. B., McEniry, B., Knight, C. T., Seigler, D., Erdman, J. W. Jr. & Lila, M. A. (2004). Effective separation of potent anti proliferation and anti-adhesion components from wild bluberry (Vaccinium angustifolium Ait) fruits. Journal of Agriculture and Food Chemistry, 52, 6433-6442.